TY  - CHAP
AU  - Ilze Strumfa
AU  - Tatjana Bogdanova
AU  - Arturs Kalva
AU  - Boriss Strumfs
AU  - 
Roberts Rumba
AU  - Andrejs Vanags
AU  - Inese Drike
AU  - Dzeina Mezale
AU  - Arnis
Abolins
AU  - Arvids Jakovlevs
AU  - Dainis Balodis
AU  - Janis Gardovskis
ED  - Gyula Mózsik
ED  - Oszkár Karádi
Y1  - 2017-09-20
PY  - 2017
T1  - Systemic Inflammatory Reaction in Gastric Cancer: Biology and Practical Implications of Neutrophil to Lymphocyte Ratio, Glasgow Prognostic Score and Related Parameters
N2  - Gastric cancer remains an important issue in the world of oncology. In 2013, it ranked fifth by global incidence and second by mortality. Really, it is true that the death rates have decreased significantly in the USA and in Europe over the  100-year period; meanwhile, gastric cancer can be characterized by poor prognosis and high mortality, with the exception of early diagnosed patients. Oncological (basic and clinical) research increased extremely in the last decades (including gastric cancer). The authors participating in this book are internationally well-known experts from 11 countries of the world, working in different fields of gastric cancer research, and they summarize the results obtained in the last years. The conclusions of these abovementioned observations fall between the findings of classical prospective, randomized, multiclinical, multinational (and meta-analyzed) generally accepted studies (in accordance with the presently applied and internationally accepted protocols) and the scientifically-based (however individual) molecular targeting organ therapies. The book gathers experts in basic science, molecular pharmacologists, biochemical pharmacologists, basic and clinical oncologists, internists, surgeons, gastroenterologists, tumor pharmacologists as well as experts working in the field of oncology.
BT  - Gastric Cancer
SP  - Ch. 8
UR  - https://doi.org/10.5772/intechopen.69723
DO  - 10.5772/intechopen.69723
SN  - 978-953-51-3528-9
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-04-20
ER  -